Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Rick Baehner"'
Autor:
Elizabeth Jane Sutton, Tobias D. Henning, Sophie Boddington, Stavros Demos, Christian Krug, Reinhardt Meier, John Kornak, Shoujun Zhao, Rick Baehner, Sheida Sharifi, Heike Daldrup-Link
Publikováno v:
Molecular Imaging, Vol 9 (2010)
The purpose of this study was to compare viable and nonviable bilabeled mesenchymal stem cells (MSCs) in arthritic joints with magnetic resonance imaging (MRI) and optical imaging (OI). MSCs were labeled with ferucarbotran and DiD. MRI and OI of bila
Externí odkaz:
https://doaj.org/article/18cdb5c3d34246ec8eec274fe5c1e56b
Autor:
Corey W. Speers, W. Fraser Symmans, William E. Barlow, Alex Trevarton, Stephanie The, Lili Du, James M. Rae, Steven Shak, Rick Baehner, Priyanka Sharma, Lajos Pusztai, Gabriel N. Hortobagyi, Daniel F. Hayes, Kathy S. Albain, Andrew Godwin, Alastair Thompson
Publikováno v:
Journal of Clinical Oncology. 41:1841-1848
PURPOSE Chemotherapy has not demonstrated benefit over adjuvant endocrine therapy alone for postmenopausal patients with node-positive breast cancer with a 21-gene breast recurrence score (RS) of 25 or below (RS ≤ 25). We tested whether combined re
Autor:
Mark Landers, Patrick Eimerman, Steve Mastrian, Tracey White, Janine LoBello, Gargi Basu, Szabolcs Szelinger, Jessica Aldrich, Matthew Halbert, Jess Hoag, David Hall, Farjana Fattah, Daniel Pointing, Luka Ausec, Anze Gregorc, Seema Iyer, Mark Uhlik, Laura Benjamin, Rick Baehner
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Rick Baehner, April S. Liang, Alexander D. Borowsky, Rita I. Freimanis, Gillian L. Hirst, Shelley Hwang, Gregor Krings, Amrita Basu, Paul Kim, Nola M. Hylton, Heather I. Greenwood, Laura J. Esserman, Rita A. Mukhtar, Case Brabham
Publikováno v:
Cancer Research. 81:PS1-03
Introduction: Standard treatment for ductal carcinoma in situ (DCIS) involves surgical excision with radiation and often endocrine therapy. However, not all DCIS progresses to invasive ductal carcinoma (IDC); thus, surgical intervention may constitut
Autor:
Matthias Christgen, Michael Hauptmann, O Gluz, Rick Baehner, Hans Kreipe, Monika Graeser, Jochem Potenberg, Kerstin Luedtke-Heckenkamp, S Shak, Bahriye Aktas, Ronald E. Kates, Nadia Harbeck, Helmut Forstbauer, Michael Braun, Ulrike Nitz, Sherko Kuemmel, Eva-Maria Grischke, Christoph Uleer, Raquel von Schumann, Rachel Wuerstlein, Claudia Schumacher, Maren Darsow
Publikováno v:
Cancer Research. 81:GS4-03
Background: Pathological complete response (pCR) is associated with improved outcome in patients with high-risk HR+/HER2- breast cancer (BC) but the use of (neo)adjuvant chemotherapy in early HR+/HER2- BC remains controversial. Oncotype DX / Recurren
Autor:
Jochem Potenberg, Wolfram Malter, Helmut Forstbauer, Matthias Christgen, Eva-Maria Grischke, Mathias Warm, Bahriye Aktas, Ronald E. Kates, Claudia Schumacher, Hans Holger Fischer, Benno Nuding, Nadia Harbeck, O Gluz, Maren Darsow, Hans Kreipe, Michael Braun, Rachel Wuerstlein, Katja Krauss, Sherko Kuemmel, S Shak, Marc Thill, Rick Baehner, Ulrike Nitz, Kerstin Luedtke-Heckenkamp, Christoph Uleer, Monika Graeser, Michael Hauptmann
Publikováno v:
Cancer Research. 81:GS4-04
Background: In HR+/HER2- N0 early breast cancer (EBC), patients (pts) with Recurrence Score™ (RS) Methods: 5625 pts were registered and 4691 finally treated by ET (n=2356) or CT (n=2335) within ADAPTHR+/HER2-. ET-trial ITT population comprised 2290
Autor:
Marianne Just, Rachel Wuerstlein, Michael J. Clemens, Henriette Christgen, Petra Krabisch, Monika Graeser, Bahriye Aktas, Ronald E. Kates, Nadia Harbeck, M. Raap, Sherko Kuemmel, O Gluz, Toralf Reimer, Benno Nuding, U. Nitz, Matthias Christgen, Hans-Heinrich Kreipe, Rick Baehner, Wolfram Malter, A. Stefek
Publikováno v:
European Journal of Cancer. 138:S1
Autor:
Bahriye Aktas, O Gluz, S Shak, H.H. Kreipe, Nadia Harbeck, S Markmann, B Liedtke, U. Nitz, Matthias Christgen, Kristina Lübbe, Michael J. Clemens, Rick Baehner, Jana Barinoff, M Salem, Cornelia Liedtke, S. Henschen
Publikováno v:
Cancer Research. 70:P3-10
Background: Despite progress in adjuvant breast cancer (BC) treatment, overtreatment due to decisions based on conventional prognostic factors (lymph nodes (LN), grade, tumor size) alone remains an important clinical problem. Recurrence Score®, RS i
Autor:
Rick Baehner, Greg Magrane, Cornell G. Chang, Carl L. Millward, Adil E. Wakil, Frederic M. Waldman, Robert W. Osorio, Ronald Balassanian
Publikováno v:
Human Pathology. 31:1425-1429
Organ transplant recipients have an increased tumor incidence owing to their imumunocompromised state. The origin of such tumors, whether donor or recipient, will have a clinical impact on decision-making concerning immunosuppressive therapy, retrans
Autor:
R Meier, Shoujun Zhao, Stavros G. Demos, Heike E. Daldrup-Link, John Kornak, Rick Baehner, Tobias D. Henning, Sophie Boddington, Elizabeth J. Sutton, Sheida Sharifi, Christian Krug
Publikováno v:
Molecular Imaging, Vol 9 (2010)
The purpose of this study was to compare viable and nonviable bilabeled mesenchymal stem cells (MSCs) in arthritic joints with magnetic resonance imaging (MRI) and optical imaging (OI). MSCs were labeled with ferucarbotran and DiD. MRI and OI of bila
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f3ee89d422fa1438430bd9094c70acd
https://europepmc.org/articles/PMC3060764/
https://europepmc.org/articles/PMC3060764/